AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 184 filers reported holding AXSOME THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.99 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,747 | +3.1% | 24,995 | +6.0% | 0.00% | +50.0% |
Q2 2023 | $1,694 | +8.2% | 23,570 | -7.1% | 0.00% | 0.0% |
Q1 2023 | $1,565 | -33.3% | 25,366 | -16.7% | 0.00% | -33.3% |
Q4 2022 | $2,348 | -99.8% | 30,439 | +41.1% | 0.00% | +200.0% |
Q3 2022 | $963,000 | +17.0% | 21,573 | +0.4% | 0.00% | 0.0% |
Q2 2022 | $823,000 | -7.6% | 21,495 | -0.2% | 0.00% | 0.0% |
Q1 2022 | $891,000 | +9.5% | 21,538 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $814,000 | -91.6% | 21,538 | -92.6% | 0.00% | -90.0% |
Q3 2021 | $9,643,000 | -52.0% | 292,555 | -1.7% | 0.01% | -52.4% |
Q2 2021 | $20,076,000 | +16.8% | 297,594 | -2.0% | 0.02% | +10.5% |
Q1 2021 | $17,191,000 | -16.9% | 303,622 | +19.5% | 0.02% | -17.4% |
Q4 2020 | $20,696,000 | +40.4% | 254,034 | +22.8% | 0.02% | +27.8% |
Q3 2020 | $14,745,000 | +34.7% | 206,952 | +55.6% | 0.02% | +28.6% |
Q2 2020 | $10,946,000 | +50.3% | 133,031 | +7.5% | 0.01% | +27.3% |
Q1 2020 | $7,283,000 | +2.2% | 123,793 | +79.5% | 0.01% | +37.5% |
Q4 2019 | $7,126,000 | +1130.7% | 68,948 | +141.1% | 0.01% | +700.0% |
Q3 2019 | $579,000 | -10.1% | 28,600 | +14.4% | 0.00% | 0.0% |
Q2 2019 | $644,000 | +1851.5% | 25,000 | +198.6% | 0.00% | – |
Q1 2017 | $33,000 | -42.1% | 8,372 | +0.0% | 0.00% | – |
Q4 2016 | $57,000 | -13.6% | 8,371 | 0.0% | 0.00% | – |
Q3 2016 | $66,000 | +4.8% | 8,371 | 0.0% | 0.00% | – |
Q2 2016 | $63,000 | – | 8,371 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALETHEA CAPITAL MANAGEMENT, LLC | 1,132,645 | $37,332,000 | 32.86% |
MORGAN JESS S & CO INC | 113,430 | $3,739,000 | 2.47% |
Fairmount Funds Management LLC | 187,598 | $6,183,000 | 2.25% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 1,423,653 | $46,924,000 | 1.43% |
WMS Partners, LLC | 250,000 | $8,240,000 | 1.21% |
Beck Bode, LLC | 102,127 | $3,366,000 | 0.94% |
RTW INVESTMENTS, LP | 1,616,497 | $53,280,000 | 0.80% |
MPM BioImpact LLC | 110,155 | $3,631,000 | 0.56% |
Endurant Capital Management LP | 52,048 | $1,716,000 | 0.39% |
Bellevue Group AG | 752,945 | $24,817,000 | 0.25% |